Private Equity Portfolio Company
Chengyuan Bio (RootPath)
Watertown, Massachusetts
United States
https://www.rootpath.com
Chengyuan Bio (RootPath Genomics) is a synthetic biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine....
Private Equity Owner: CDH Investments
Acquisition Criteria
Investment Date:
Exit Date:
Status:
Add-on Acquisitions:
Industry (NAICS Code):
Testimonials
Become the next customer to share a success story about Private Equity Info's impact.
"Private Equity Info is critical to nearly every aspect of our role as an investment bank. We use it almost every day and the return on investment is clear."
Bob McCormack
"PEI is superior for our sales team. It cuts to the core. It’s the sweet spot in terms of what you’re paying and what you’re getting.”
